MedGenome IPO

research.medgenome.com

MedGenome is a provider of personalized medicine and genomic solutions in immuno-oncology, diabetes, ophthalmology, cardiology and other rare diseases. Additionally, MedGenome's wet lab capabilities have allowed for solutions that enable pharma and biotech companies to accelerate early drug discovery pipelines as well as aid biomarker discoveries for companion diagnostics programs.

Founded2013
Register for Details

For more details on financing and valuation for MedGenome, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

MedGenome Ticker Symbol

MedGenome does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

MedGenome Stock Price

The stock price for MedGenome will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Major Investors for MedGenome

Sequoia Capital
International Finance Corporation
Sofina
Novo Holdings
LeapFrog Holdings
HDFC
InnoVen Capital

Other companies like MedGenome in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B